Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Viral Structure00:56

Viral Structure

67.0K
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
67.0K
Size and Structure of Viral Genomes01:26

Size and Structure of Viral Genomes

250
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
250
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

229
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
229

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Phase Ib IMPACT Trial of Intramuscular Personalized Neoantigen Synthetic Long Peptide Vaccines in Patients with Advanced Melanoma and Renal Cell Carcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Author Correction: Magnon confinement in epitaxial antiferromagnetic oxide heterostructures.

Nature materials·2026
Same author

Inducible POU Class 2 Homeobox 3 Expression in Human Intestinal Organoids as a Model of Human Tuft Cells.

Cellular and molecular gastroenterology and hepatology·2026
Same author

Magnon confinement in epitaxial antiferromagnetic oxide heterostructures.

Nature materials·2026
Same author

Differential effects of adolescent fatty acid amide hydrolase and monoacylglycerol lipase inhibition on adolescent and adult behaviors in male rats.

Psychopharmacology·2026
Same author

Tulane virus protease as a structural surrogate for inhibitor screening of human norovirus proteases.

Journal of virology·2026

Related Experiment Video

Updated: Oct 15, 2025

Production of Human Norovirus Protruding Domains in E. coli for X-ray Crystallography
10:46

Production of Human Norovirus Protruding Domains in E. coli for X-ray Crystallography

Published on: April 19, 2016

8.8K

Norovirus Protease Structure and Antivirals Development.

Boyang Zhao1, Liya Hu2, Yongcheng Song3

  • 1Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA.

Viruses
|October 26, 2021
PubMed
Summary
This summary is machine-generated.

Developing effective human norovirus (HuNoV) protease inhibitors is challenging due to enzyme variability. This review analyzes HuNoV protease structures to guide the design of broad-spectrum antiviral drugs.

Keywords:
antiviralsnorovirusproteasestructure

More Related Videos

Alternative In Vitro Methods for the Determination of Viral Capsid Structural Integrity
12:57

Alternative In Vitro Methods for the Determination of Viral Capsid Structural Integrity

Published on: November 16, 2017

8.4K
Quantifying Human Norovirus Virus-like Particles Binding to Commensal Bacteria Using Flow Cytometry
07:02

Quantifying Human Norovirus Virus-like Particles Binding to Commensal Bacteria Using Flow Cytometry

Published on: April 29, 2020

8.1K

Related Experiment Videos

Last Updated: Oct 15, 2025

Production of Human Norovirus Protruding Domains in E. coli for X-ray Crystallography
10:46

Production of Human Norovirus Protruding Domains in E. coli for X-ray Crystallography

Published on: April 19, 2016

8.8K
Alternative In Vitro Methods for the Determination of Viral Capsid Structural Integrity
12:57

Alternative In Vitro Methods for the Determination of Viral Capsid Structural Integrity

Published on: November 16, 2017

8.4K
Quantifying Human Norovirus Virus-like Particles Binding to Commensal Bacteria Using Flow Cytometry
07:02

Quantifying Human Norovirus Virus-like Particles Binding to Commensal Bacteria Using Flow Cytometry

Published on: April 29, 2020

8.1K

Area of Science:

  • Virology
  • Structural Biology
  • Drug Discovery

Background:

  • Human norovirus (HuNoV) infections represent a significant global health and economic burden.
  • There are currently no licensed vaccines or antiviral therapies available for HuNoV.
  • The HuNoV protease is essential for viral replication and a key target for small-molecule inhibitors.

Purpose of the Study:

  • To conduct a comparative analysis of available HuNoV protease structures.
  • To identify novel strategies for designing broad-spectrum HuNoV protease inhibitors.
  • To provide an overview of the current status of HuNoV protease inhibitor development.

Main Methods:

  • Comparative structural analysis of human norovirus protease.
  • Review of existing strategies for designing protease inhibitors.
  • Examination of substrate-binding pockets and active site variations.

Main Results:

  • Subtle conformational flexibility and structural differences across HuNoV genogroups hinder broad-spectrum inhibitor development.
  • Current strategies targeting active sites and nearby pockets face challenges due to enzyme variability.
  • Structural insights are crucial for overcoming limitations in current inhibitor design.

Conclusions:

  • A deeper understanding of HuNoV protease structural dynamics is needed.
  • Novel strategies informed by comparative structural analysis are essential for developing effective broad-spectrum antivirals.
  • This review provides a foundation for future research in HuNoV protease inhibitor design.